Skip to content

Effect of Mouth wash

A RANDOMIZED OPEN LABEL PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF NANOLIFE MOUTH WASH (Silver 100% Nano particle) ON GINGIVAL HEALTH.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017396
Enrollment
24
Registered
2019-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K050- Acute gingivitis

Interventions

Intervention1: Nano life (silver 100% nano particle) Mouth wash for oral and dental infectious conditions: Rajata Bhasma Liquid - 20 ppm with flavors added Flavors used : Clove bud extract, peppermint

Sponsors

DHANVANTARI NANO AYUSHADI PVt LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Systemically healthy subjects diagnosed with Gingivitis, in the age group of 18-35 years, and who agreed to comply with the study visits were included

Exclusion criteria

Exclusion criteria: Subjects with mal-aligned teeth, wearing orthodontic appliances and removable partial dentures; subjects with chronic or aggressive periodontitis; subjects with history of oral prophylaxis within past six months; tobacco consumers and smokers, subjects on any antibiotic therapy in past three months and subjects with medical or pharmacological history that could compromise the conduct of the study Subject who are pregnant or nursing. Subjects with hypersensitivity to any of the test products.

Design outcomes

Primary

MeasureTime frame
Assessment and comparison of Oral Hygiene Index - Simplified (OHI-S), Plaque Index (PI) and Gingival Index (GI) on day 7 and 14. The average reduction in the number of colony-forming units of bacterial and fungal, from samples before and after using the mouth wash on day 1,7 and 14. Timepoint: Assessment and comparison of Oral Hygiene Index - Simplified (OHI-S), Plaque Index (PI) and Gingival Index (GI) on day 7 and 14. The average reduction in the number of colony-forming units of bacterial and fungal, from samples before and after using the mouth wash on day 1,7 and 14.

Secondary

MeasureTime frame
To monitor for any adverse events during the study period of 14 days.Timepoint: Day 1 to 14

Countries

India

Contacts

Public ContactDr Ramesh Kannan
srkguruvarshan@gmail.com7708925866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026